Medication info
Telmion Tablet 40 mg (Telmisartan)

Telmion Tablet 40 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tablet
Manufacturer / importer
Korea Chorus Co., Ltd.
Appearance
White oval-shaped tablet
Packaging
30 tablets (10 tablets/AluAlu*3)
Approval status
Active

MFDS item code 201800785 · Approved 2018.02.09 · Insurance code 647204980

Summary

Main use
Treatment of essential hypertension; prevention of cardiovascular disease in high-risk patients
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. For some patients, 20 mg once daily may be effective. If necessary, the dose may be increased to 80 mg once daily. The maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine has an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: This medicine is recommended at 80 mg orally once daily with water and may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be necessary. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Korea Chorus Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; prevention of cardiovascular disease in high-risk patients

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attack
  • high-risk diabetes with clinical evidence of end-organ damage
  • myocardial infarction
View approved original text

This medication is used to control essential hypertension. Additionally, it helps to reduce the risk of death from myocardial infarction, stroke, and cardiovascular disease in patients aged 55 and older with a history of coronary artery disease, peripheral artery disease, stroke, or transient ischemic attack, or in patients with high-risk diabetes. It is especially suitable for those who cannot use ACE inhibitors. This drug is effective in lowering the risk of cardiovascular disease and treating hypertension. Overall, it is used to improve heart and vascular health.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. For some patients, 20 mg once daily may be effective. If necessary, the dose may be increased to 80 mg once daily. The maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine has an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: This medicine is recommended at 80 mg orally once daily with water and may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be necessary. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can cause serious harm during pregnancy, especially to the fetus and newborn, so use must be discontinued immediately upon confirmation of pregnancy. It should not be used in individuals allergic to this medication or its components, in pregnant or breastfeeding women, or in patients with severe liver disease or bile duct obstruction. It should also not be administered to patients who are genetically unable to break down lactose. Caution is needed in elderly patients or those with high potassium levels, mild to moderate liver impairment, heart valve disease, or ischemic heart disease when using this medication. In patients with hypertension, adverse reactions occurred with a frequency similar to placebo; however, serious side effects such as angioedema, hyperkalemia, renal impairment, shock, and liver dysfunction can occur rarely, necessitating caution. Particularly, if symptoms of angioedema appear, use should be stopped immediately, and appropriate treatment should be obtained. In patients with renal impairment, it is important to regularly monitor potassium and creatinine levels. Patients with decreased blood volume or sodium deficiency may experience hypotension, so these conditions should be corrected before taking this medication. While this medication may enhance the effect when taken with other antihypertensives, caution is advised as the risk of renal function deterioration or hyperkalemia may increase when combined with certain drugs. It should not be used during pregnancy, and during breastfeeding, it is preferable to avoid administration or discontinue breastfeeding. Safety and efficacy in children under 18 years of age have not been established, hence it is not recommended. In case of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur, requiring immediate treatment and monitoring of the patient's status. This medication should be kept out of reach of children and must be stored sealed until just before administration.

Side effects

  • Upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 113 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbance
  • abnormal liver function
  • liver disorder
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • asthenia
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • elevated liver enzymes
  • increased serum creatine kinase
  • decreased hemoglobin
  • hypoglycemia
  • weakness
  • hunger
  • cold sweat
  • hand tremor
  • decreased concentration
  • convulsions
  • altered consciousness
  • facial swelling
  • lip swelling
  • oropharyngeal swelling
  • tongue swelling
  • severe hyperkalemia
  • renal failure
  • shock
  • loss of consciousness
  • liver dysfunction
  • jaundice
  • difficulty breathing
  • hypotension
  • laryngeal edema
  • fever
  • pneumonia
  • myalgia
  • increased creatine kinase
  • elevated serum myoglobin
  • increased urinary myoglobin
  • palpitations
  • fatigue
  • nausea
  • lack of efficacy
  • headache
  • dizziness
  • cough
  • dyspepsia
  • arrhythmia
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • loss of appetite
  • edema
  • decreased libido
  • facial edema
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • headache
  • dizziness
  • myalgia
  • dermatitis
  • dizziness
  • dyspepsia
  • cough
  • abdominal pain
  • loss of appetite
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

White oval-shaped tablet

Package unit

30 tablets (10 tablets/AluAlu*3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.